In gene therapy for ADA deficiency, a functional ADA cDNA is carried into the patient's lymphocytes by a retroviral vector.
Why is a virus suitable for this job?
Confirming your payment
Competency-Based Questions (CBQ) · Question 24 of 80
In gene therapy for ADA deficiency, a functional ADA cDNA is carried into the patient's lymphocytes by a retroviral vector.
Why is a virus suitable for this job?
(A) The virus destroys the patient's defective lymphocytes, making room for healthy ones.
(B) The virus makes the lymphocytes immortal, so a single treatment lasts for life.
(C) Viruses introduce their genetic material into the host cell as part of their replication cycle, so they can deliver the ADA cDNA into the lymphocytes.
(D) The virus supplies the ADA enzyme itself, so the lymphocytes do not need the gene.
Option (C) is correct.
Explanation: NCERT explains that viruses which attack their hosts introduce their genetic material into the host cell as part of their replication cycle. That is why they are used as vectors to transfer healthy genes. In ADA therapy, the retroviral vector delivers the functional ADA cDNA into the cultured lymphocytes, which are then returned to the patient.